Literature DB >> 1746678

Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi.

D R Pulitzer1, P C Martin, A P Cohen, R J Reed.   

Abstract

The designation combined nevus gives recognition to mixed cytologic patterns. In the common variant, plump, pigmented spindle cells form fascicles among nests of ordinary nevus cells. In other variants, one or several cellular components that share cytologic features with either a blue nevus or a Spitz nevus are represented. Ninety-five cases, 49% of which were of the common type, were studied. Grossly, most of the lesions were darkly pigmented papules or nodules. The clinical diagnosis in three-fourths of the cases was nevus, blue nevus, or melanoma. Fifteen percent had concomitant histologic features of melanocytic dysplasia, and most of these lesions were of the common type. For the common variant, the cytologic features, pattern of apparent infiltration, and variable representation of the features of a premalignant melanocytic dysplasia often mislead a pathologist in interpreting and predicting biologic potential. In combined nevi, the phenotypic diversity and genetic lability of melanocytic nevus cells is manifested.

Entities:  

Mesh:

Year:  1991        PMID: 1746678     DOI: 10.1097/00000478-199112000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  Combined nevi of the conjunctiva.

Authors:  J B Crawford; E L Howes; D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1999

Review 2.  Problematic pigmented lesions: approach to diagnosis.

Authors:  S L Edwards; K Blessing
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

3.  SkIndia Quiz 33: Solitary pigmented plaque containing a blue-gray papule.

Authors:  Cody J Connor; Brian L Swick
Journal:  Indian Dermatol Online J       Date:  2017 Jan-Feb

Review 4.  The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification.

Authors:  Tiffany W Cheng; Madeline C Ahern; Alessio Giubellino
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.